CD73 inhibitors offer significant market opportunities in cancer treatment through novel immunotherapies. Promising developments include monoclonal antibodies, nucleotides, and non-nucleotides, with ...
Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...
Rhabdomyosarcoma Market is Expected to Rise Throughout Forecast Period (2025-2034) with Promising Drug Candidates in Pipeline | DelveInsight ...
Detailed price information for Theriva Biologics Inc (TOVX-A) from The Globe and Mail including charting and trades.
The outlook for the KLKB1 inhibitors market is increasingly positive, driven by growing recognition of the kallikrein–kinin ...
New drug therapies focusing on anti-inflammatory, enzyme inhibition, and organ protection are reshaping the treatment landscape. Despite challenges such as high treatment costs, ongoing research in ...
The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 ...
A proteolytically inactive BACE1 knock-in (BACE1-KI, D289N) is compared with a BACE1 knockout (BACE1-KO) mouse to dissect ...
Protein kinases are the molecular switches of the cell. They control growth, division, communication, and survival by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback